Andrew Dudum, chief executive officer of telehealth company Hims & Hers Health (HIMS), has been a consistent seller of company stock over the period covered by SEC Form 4 filings. Across 76 transactions, he has disposed of shares worth approximately $73.7 million with no open-market purchases recorded. The selling activity is concentrated in the "S" code—open-market sales—which reflects a deliberate reduction of his position rather than automatic or mechanical dispositions. Notably, there are no recent buys of any kind, and the most recent transactions in June 2026 are a mix of option exercises (code "M") and shares withheld for tax obligations (code "F"), the latter totaling roughly $2.58 million. This pattern suggests that while Dudum continues to exercise options tied to his compensation, he is not adding to his stake through the open market.
The filings also reveal significant non-sale activity that contextualizes the selling. In March 2026, Dudum received equity awards (code "A") and executed option exercises, followed by tax-withholding dispositions of $2.24 million and $10.8 million on March 13. These "F" transactions are automatic and tied to covering the tax liability from vesting or exercising options, not discretionary selling. Additionally, he made several gifts (code "G") in late 2025—on November 10, November 12, and November 28—with no dollar value attached, indicating transfers of shares without monetary exchange. The overall picture is one of a CEO who is monetizing his holdings through planned sales while also managing the administrative consequences of his equity compensation, with no indication of fresh capital being deployed into the company's stock.
AI-assisted summary